AU2001288690A1 - Two-component anti-emetic composition comprising dexamethasone and metoclopramide - Google Patents

Two-component anti-emetic composition comprising dexamethasone and metoclopramide

Info

Publication number
AU2001288690A1
AU2001288690A1 AU2001288690A AU8869001A AU2001288690A1 AU 2001288690 A1 AU2001288690 A1 AU 2001288690A1 AU 2001288690 A AU2001288690 A AU 2001288690A AU 8869001 A AU8869001 A AU 8869001A AU 2001288690 A1 AU2001288690 A1 AU 2001288690A1
Authority
AU
Australia
Prior art keywords
metoclopramide
dexamethasone
component anti
emetic composition
emetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001288690A
Inventor
Anthony Jannetta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ODYSSEY PHARMACEUTICALS LLC
Original Assignee
ODYSSEY PHARMACEUTICALS LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ODYSSEY PHARMACEUTICALS LLC filed Critical ODYSSEY PHARMACEUTICALS LLC
Publication of AU2001288690A1 publication Critical patent/AU2001288690A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001288690A 2000-09-05 2001-09-05 Two-component anti-emetic composition comprising dexamethasone and metoclopramide Abandoned AU2001288690A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22954700P 2000-09-05 2000-09-05
US60/229,547 2000-09-05
PCT/US2001/027405 WO2002020001A2 (en) 2000-09-05 2001-09-05 Two-component anti-emetic composition comprising dexamethasone and metoclopramide

Publications (1)

Publication Number Publication Date
AU2001288690A1 true AU2001288690A1 (en) 2002-03-22

Family

ID=22861704

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001288690A Abandoned AU2001288690A1 (en) 2000-09-05 2001-09-05 Two-component anti-emetic composition comprising dexamethasone and metoclopramide

Country Status (4)

Country Link
US (1) US20020055495A1 (en)
EP (1) EP1357916A2 (en)
AU (1) AU2001288690A1 (en)
WO (1) WO2002020001A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7744916B2 (en) * 1997-06-11 2010-06-29 Umd, Inc. Coated vaginal device for delivery of anti-migraine and anti-nausea drugs
US20040043071A1 (en) * 2002-06-21 2004-03-04 Pauletti Giovanni M. Intravaginal mucosal or transmucosal delivery of antimigraine and antinausea drugs
US6673792B1 (en) * 2002-07-11 2004-01-06 Upchuck, Llc Broad-spectrum anti-emetic compositions and associated methods
US20050282879A1 (en) * 2004-06-17 2005-12-22 Foad Salehani Methods and composition for treatment of migraine and symptoms thereof
WO2008103852A1 (en) * 2007-02-21 2008-08-28 Victory Pharma, Inc. Transdermal delivery of dexamethasone and promethazine
KR101368587B1 (en) * 2010-12-27 2014-03-05 주식회사 삼양바이오팜 Composition for prevention of nausea or vomiting
US10537585B2 (en) 2017-12-18 2020-01-21 Dexcel Pharma Technologies Ltd. Compositions comprising dexamethasone
US11878049B1 (en) * 2019-06-14 2024-01-23 Agios Pharmaceuticals, Inc. Mitapivat therapy and modulators of cytochrome P450
WO2023179542A1 (en) 2022-03-21 2023-09-28 Gasherbrum Bio , Inc. 5,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetes
WO2023198140A1 (en) 2022-04-14 2023-10-19 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661142A (en) * 1996-04-17 1997-08-26 Naeger; David M. Anti-emetic composition

Also Published As

Publication number Publication date
WO2002020001A3 (en) 2003-08-21
WO2002020001A2 (en) 2002-03-14
US20020055495A1 (en) 2002-05-09
EP1357916A2 (en) 2003-11-05

Similar Documents

Publication Publication Date Title
AU2001294814A1 (en) Pumpcn compositions and uses thereof
AU3731600A (en) Composition and structures made therefrom
AU2000279411A1 (en) New pigments and compositions containing them
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2002210988A1 (en) Natural rubber produced from latex and composition comprising the same
AU2001219651A1 (en) Mulch composition and method
AU2003227263A1 (en) Phosphor and phosphor composition containing the same
AU3495199A (en) Abrasive silica compositions and dentifrice compositions prepared therefrom
AU2349399A (en) R-lansoprazole compositions and methods
AU2002219135A1 (en) Substituted 2-anilino-benzimidazoles and the use thereof as NHE-inhibitors
AU2001293728A1 (en) Cosmetic composition
AU1403501A (en) Novel composition and use
AU2001292047A1 (en) Composition containing an azaphthalocyanine and use
AU2001288690A1 (en) Two-component anti-emetic composition comprising dexamethasone and metoclopramide
AU2000278058A1 (en) Cosmetic composition having improved absorption and adhesion characteristics
AU1152601A (en) Compositions and their use
AU4432001A (en) Trityl-type compounds and their use
AU4328700A (en) Pseudomycin antifungal compositions and methods for their use
AU2000243472A1 (en) Cosmetic resin composition and cosmetic using the same
AU6509899A (en) Odor-control methods and compositions
AU2001241117A1 (en) Fused-benzoyl derivatives and herbicide compositions containing the same
AU2002220804A1 (en) Composition containing 7-hydroxy dhea and/or 7-keto dhea and at least a carotenoid
AU5931300A (en) Ringene compositions and methods for use thereof
AU5688299A (en) Light-emission-enhancement microbead paint compositions and their preparation
AU2001260720A1 (en) Photosensitive resin composition and photosensitive material using the same